OCA
VRNA
Octagon Capital Advisors’s Verona Pharma VRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9M | Buy |
337,000
+119,736
| +55% | +$11.3M | 7% | 3 |
|
|
2025
Q1 | $13.8M | Sell |
217,264
-354,000
| -62% | -$22.5M | 2.67% | 14 |
|
|
2024
Q4 | $26.5M | Sell |
571,264
-1,263,936
| -69% | -$58.7M | 4.37% | 5 |
|
|
2024
Q3 | $52.8M | Sell |
1,835,200
-60,000
| -3% | -$1.73M | 8.21% | 2 |
|
|
2024
Q2 | $27.4M | Sell |
1,895,200
-473,800
| -20% | -$6.85M | 4.31% | 7 |
|
|
2024
Q1 | $38.1M | Hold |
2,369,000
| – | – | 4.57% | 4 |
|
|
2023
Q4 | $47.1M | Hold |
2,369,000
| – | – | 7.54% | 3 |
|
|
2023
Q3 | $38.6M | Sell |
2,369,000
-99,000
| -4% | -$1.61M | 5.93% | 4 |
|
|
2023
Q2 | $52.2M | Hold |
2,468,000
| – | – | 7.26% | 2 |
|
|
2023
Q1 | $49.6M | Hold |
2,468,000
| – | – | 7.13% | 3 |
|
|
2022
Q4 | $64.5M | Buy |
2,468,000
+1,143,132
| +86% | +$29.9M | 10.04% | 3 |
|
|
2022
Q3 | $13.5M | Buy |
+1,324,868
| New | +$13.5M | 2.34% | 10 |
|